Medtronic today announced that it received National Medical Products Administration approval in China for its CoreValve Evolut Pro TAVR system. The approval marks the first Medtronic TAVR system approved in China for patients with symptomatic severe aortic stenosis who are at high or extreme risk for open-heart surgery, according to the company. Medtronic’s approval of […]
Cardiovascular
Welcome to MassDevice's Cardiovascular Hub, your resource for the latest news in cardiac implants, structural heart, heart valves, stents and more. Stay informed about the innovations and business news shaping the cardiovascular device industry.
🫀 Narrow your focus with these categories:
Cardiac Implants | Structural Heart | Pulsed-Field Ablation
Here are top cardiology features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ LVADs save lives: So why aren’t more available?
+ How Medtronic uses nitinol to improve the structure and effectiveness of heart devices
+ How Abbott designed the world’s first dual-chamber leadless pacemaker system
+ J&J used RWE for expanded indications — and you can, too
+ 7 cardiology startups you need to know
Latest Cardiology News
Medtronic to acquire cardiac arrhythmia treatment developer Affera
Medtronic (NYSE:MDT) announced today that it agreed to acquire cardiac mapping and ablation technology developer Affera. Medtronic CEO Geoff Martha described the deal as a nearly $1 billion transaction at the J.P. Morgan Healthcare Conference today, though he added it includes a $250 million contingent consideration. The company expects the transaction to close in the […]
CES 2022: Medical technologies you need to know
Over 2,200 companies from around the world exhibited at this year’s CES. Nearly a fifth — 417 — were digital health companies. Wearables continue to an important role at the event, which remains hybrid virtual and in-person amid the COVID-19 pandemic. There were 276 fitness and wearables exhibitors this year, 56 more than last year. This […]
How Abbott seeks to improve care, health inequities for people with cardiovascular disease
Abbott is on a mission to grasp the scope of the patient journey through cardiovascular disease diagnosis and treatment. The company’s Beyond Intervention Initiative kicked off a few years ago to improve patient care and quality of life. What Abbott found was that there is plenty of ground to make up. “That’s what all these life-changing technologies that […]
AngioDynamics slides on mixed bag Q2
AngioDynamics (NSDQ:ANGO) shares took a hit today on second-quarter results that were mixed compared to the consensus forecast. The Latham, N.Y.-based peripheral artery disease (PAD) treatment developer posted losses of $8.4 million, or 21¢ per share, on sales of $78.3 million for the three months ended Nov. 30, 2021, nearly doubling its losses from the […]
Neovasc enrolls first patient in refractory angina treatment trial
Neovasc (NSDQ:NVCN) announced today that it enrolled the first patient in the Cosira-II clinical trial for its Neovasc Reducer. Vancouver, Canada-based Neovasc’s Cosira-II (coronary sinus reducer for the treatment of refractory angina) pivotal trial will study the safety and effectiveness of the Reducer in reducing angina symptoms in those with refractory angina. According to a […]
GE Healthcare, Boston Scientific collaborate in Asia for interventional cardiac care
GE Healthcare (NYSE:GE) announced today that it is collaborating with Boston Scientific (NYSE:BSX) on cardiac care in Southeast Asia. The companies tout the collaboration as the first of its kind. They will combine their interventional cardiology portfolios to provide a comprehensive offering ranging from diagnostic to percutaneous coronary intervention (PCI) to cardiac care centers in […]
Withings plans launch for Body Scan smart scale platform
Withings is promoting its Body Scan in-home connected health station smart scale platform, with a launch planned later this year. Las Vegas-based Withings’ Body Scan goes beyond weight management to offer a way for users to take proactive control over their health with segmental body composition, heart rate and vascular age monitoring, according to a […]
Abbott sees the delivery system as a differentiator for its TAVR
A top Abbott executive explains how the company’s FlexNav delivery system could make the Portico TAVR competitive. Abbott is aiming to claw away market share from transcatheter aortic valve replacement pioneers Edwards Lifesciences and Medtronic. The Abbott Park, Illinois–based medtech company in September announced FDA approval of its Portico with FlexNav TAVR system, more than […]
Our top medtech stories of 2021
Covering the medical device industry enables writers to report on a wide range of world-changing news – financial markets, the pandemic, and the global supply chain problems – while also centering on jaw-dropping technology that improve patient care. You’ll hear all those issues covered in our editorial’s team summation of their Top Stories of 2021 […]
FDA approves Philips’ laser-based device for removing inferior vena cava filters
The FDA today announced the authorization of the first laser-based device for removing IVC filters, developed by Royal Philips (NYSE:PHG). Authorization came through the de novo pathway, with Philips’ device receiving FDA breakthrough device designation for removing IVC (inferior vena cava) filters. Philips designed the device for patients who have an IVC (inferior vena cava) […]